Substituted propanamides as inhibitors of nucleases
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Patent |
| MU Faculty or unit | |
| Publisher | IP Australia |
| State | Australia |
| Patent's number | AU2019256672 |
| Web | https://worldwide.espacenet.com/patent/search?q=pn%3DAU2019256672B2 |
| Description | Compounds represented by the structural formula (1) where R1, R2, R3, R4, R5, R6 are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases. |
| Related projects: |